BioSpace News Archive

Arkin Holdings, the largest and leading Israel-based life sciences investor, today announced a new partnership, Arkin Bio-Ventures II, to be funded with $140 million in capital commitments, from Arkin Holdings as well as an investor group including Migdal and Phoenix Group.

NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced that its RNS® System has received U.S. Food and Drug Administration (FDA) approval of MRI labeling for the RNS System, expanding treatment options for the approximately one million patients in the United States living with seizures that do not respond to medication.

Exagen Inc. (Nasdaq: XGN), today announced three large medical groups across California have contracted with Exagen Inc. to offer AVISE testing as a covered benefit for patients suspected of having autoimmune disease.

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that the class action and related books and records litigation brought by Alpha Holdings, Inc. (“Alpha”) in Nevada state court have been dismissed, with prejudice.

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) announces four projects selected to receive support directed towards improving the quality of care for advanced ovarian cancer patients

Report Highlights Excellence in Promoting Sustainable Operations, Inspiring Associates and Supporting Healthy Communities

AbbVie (NYSE:ABBV) today confirmed the company’s activities in the fight to address the COVID-19 public health crisis, including supporting the experimental use of the HIV medicine, Kaletra/Aluvia (lopinavir/ritonavir) to determine its efficacy in the treatment of COVID-19.

The Nashville Health Care Council announced the launch of Health Career Connect, an online job forum designed to connect health care employers and non-clinical talent.

The St. Baldrick’s Foundation recognizes its 20th anniversary of shaving heads to support the advancement of pediatric cancer treatments.

Advanced technology to aid in recovery of stroke, spinal cord injury and brain injury